TP53 and gastric cancer: Here, we demonstrate that SLC7A9 expression is upregulated in TP53-deficient gastric cancer, and that upregulation of SLC7A9 induces chemoresistance by inhibiting ferroptosis, independent of SLC7A11, suggesting that SLC7A9 acts as a ferroptosis suppressor.